Skip to Main content Skip to Navigation
Journal articles

A bacteriophage journey at the European Medicines Agency.

Laurent Debarbieux 1, 2 Jean-Paul Pirnay 2 Gilbert Verbeken 2 Daniel de Vos 2 Maia Merabishvili 2 Isabelle Huys 2 Olivier Patey 2 Dirk Schoonjans 2 Mario Vaneechoutte 2 Martin Zizi 2 Christine Rohde 3, 2, *
* Corresponding author
1 BMGE - Biologie Moléculaire du Gène chez les Extrêmophiles
2 Queen Astrid Military Hospital [Brussels]
3 DSMZ - Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH / Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures
Abstract : One sentence summary: The seriously and globally increasing bacterial multi-drug resistance calls out on concerted counteractive measures: international health authorities give consideration to the therapeutical use of bacteriophage therapy
Document type :
Journal articles
Complete list of metadata

Cited literature [7 references]  Display  Hide  Download
https://hal-pasteur.archives-ouvertes.fr/pasteur-01539082
Contributor : Laurent Debarbieux <>
Submitted on : Wednesday, June 14, 2017 - 1:46:50 PM
Last modification on : Monday, January 13, 2020 - 5:08:07 PM
Long-term archiving on: : Tuesday, December 12, 2017 - 12:37:55 PM

File

Vignette du document
fnv225.pdf
Publication funded by an institution

Licence

Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

PASTEUR

Citation

Laurent Debarbieux, Jean-Paul Pirnay, Gilbert Verbeken, Daniel de Vos, Maia Merabishvili, et al.. A bacteriophage journey at the European Medicines Agency.. FEMS Microbiology Letters, Wiley-Blackwell, 2016, 363 (2), pp.fnv225. ⟨10.1093/femsle/fnv225⟩. ⟨pasteur-01539082⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

162

Files downloads

704